Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Dissecting FcγR Regulation through a Multivalent Binding Model.

Robinett RA, Guan N, Lux A, Biburger M, Nimmerjahn F, Meyer AS.

Cell Syst. 2018 Jun 20. pii: S2405-4712(18)30236-9. doi: 10.1016/j.cels.2018.05.018. [Epub ahead of print]

PMID:
29960887
2.

Correction: Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease.

Uderhardt S, Ackermann JA, Fillep T, Hammond VJ, Willeit J, Santer P, Mayr M, Biburger M, Miller M, Zellner KR, Stark K, Zarbock A, Rossaint J, Schubert I, Mielenz D, Dietel B, Raaz-Schrauder D, Ay C, Gremmel T, Thaler J, Heim C, Herrmann M, Collins PW, Schabbauer G, Mackman N, Voehringer D, Nadler JL, Lee JJ, Massberg S, Rauh M, Kiechl S, Schett G, O'Donnell VB, Krönke G.

J Exp Med. 2018 Mar 5;215(3):1003. doi: 10.1084/jem.2016107002142018c. Epub 2018 Feb 20. No abstract available.

3.

Tumor location determines tissue-specific recruitment of tumor-associated macrophages and antibody-dependent immunotherapy response.

Lehmann B, Biburger M, Brückner C, Ipsen-Escobedo A, Gordan S, Lehmann C, Voehringer D, Winkler T, Schaft N, Dudziak D, Sirbu H, Weber GF, Nimmerjahn F.

Sci Immunol. 2017 Jan 6;2(7). pii: eaah6413. doi: 10.1126/sciimmunol.aah6413.

PMID:
28783667
4.

Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease.

Uderhardt S, Ackermann JA, Fillep T, Hammond VJ, Willeit J, Santer P, Mayr M, Biburger M, Miller M, Zellner KR, Stark K, Zarbock A, Rossaint J, Schubert I, Mielenz D, Dietel B, Raaz-Schrauder D, Ay C, Gremmel T, Thaler J, Heim C, Herrmann M, Collins PW, Schabbauer G, Mackman N, Voehringer D, Nadler JL, Lee JJ, Massberg S, Rauh M, Kiechl S, Schett G, O'Donnell VB, Krönke G.

J Exp Med. 2017 Jul 3;214(7):2121-2138. doi: 10.1084/jem.20161070. Epub 2017 May 31. Erratum in: J Exp Med. 2018 Feb 20;:.

5.

bIgG time for large eaters: monocytes and macrophages as effector and target cells of antibody-mediated immune activation and repression.

Gordan S, Biburger M, Nimmerjahn F.

Immunol Rev. 2015 Nov;268(1):52-65. doi: 10.1111/imr.12347. Review.

PMID:
26497512
6.

Three blocks are not enough--Blocking of the murine IgG receptor FcγRIV is crucial for proper characterization of cells by FACS analysis.

Biburger M, Trenkwald I, Nimmerjahn F.

Eur J Immunol. 2015 Sep;45(9):2694-7. doi: 10.1002/eji.201545463. Epub 2015 Jul 21. No abstract available.

7.

How immunoglobulin G antibodies kill target cells: revisiting an old paradigm.

Biburger M, Lux A, Nimmerjahn F.

Adv Immunol. 2014;124:67-94. doi: 10.1016/B978-0-12-800147-9.00003-0. Review.

PMID:
25175773
8.

B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo.

Schwab I, Seeling M, Biburger M, Aschermann S, Nitschke L, Nimmerjahn F.

Eur J Immunol. 2012 Dec;42(12):3302-9. doi: 10.1002/eji.201242710. Epub 2012 Oct 16.

9.

FcγRIIB: a modulator of cell activation and humoral tolerance.

Lehmann B, Schwab I, Böhm S, Lux A, Biburger M, Nimmerjahn F.

Expert Rev Clin Immunol. 2012 Mar;8(3):243-54. doi: 10.1586/eci.12.5. Review.

PMID:
22390489
10.

Low level of FcγRIII expression on murine natural killer cells.

Biburger M, Nimmerjahn F.

Immunol Lett. 2012 Mar 30;143(1):53-9. doi: 10.1016/j.imlet.2012.01.002. Epub 2012 Jan 21.

PMID:
22285694
11.

IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.

Schwab I, Biburger M, Krönke G, Schett G, Nimmerjahn F.

Eur J Immunol. 2012 Apr;42(4):826-30. doi: 10.1002/eji.201142260.

12.

Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo.

Biburger M, Aschermann S, Schwab I, Lux A, Albert H, Danzer H, Woigk M, Dudziak D, Nimmerjahn F.

Immunity. 2011 Dec 23;35(6):932-44. doi: 10.1016/j.immuni.2011.11.009. Epub 2011 Dec 8.

13.

Mechanisms of action of intravenous immunoglobulins.

Baerenwaldt A, Biburger M, Nimmerjahn F.

Expert Rev Clin Immunol. 2010 May;6(3):425-34. doi: 10.1586/eci.10.9. Review.

PMID:
20441428
14.

The role of Fcgamma receptors in murine autoimmune thrombocytopenia.

Biburger M, Aschermann S, Lux A, Nimmerjahn F.

Ann Hematol. 2010 Jul;89 Suppl 1:25-30. Epub 2010 Feb 24. Review.

PMID:
20179927
15.

The pro and anti-inflammatory activities of immunoglobulin G.

Lux A, Aschermann S, Biburger M, Nimmerjahn F.

Ann Rheum Dis. 2010 Jan;69 Suppl 1:i92-96. doi: 10.1136/ard.2009.117101. Review.

PMID:
19995755
16.

The other side of immunoglobulin G: suppressor of inflammation.

Aschermann S, Lux A, Baerenwaldt A, Biburger M, Nimmerjahn F.

Clin Exp Immunol. 2010 May;160(2):161-7. doi: 10.1111/j.1365-2249.2009.04081.x. Epub 2009 Dec 16. Review.

17.

Pivotal Advance: Heme oxygenase 1 expression by human CD4+ T cells is not sufficient for their development of immunoregulatory capacity.

Biburger M, Theiner G, Schädle M, Schuler G, Tiegs G.

J Leukoc Biol. 2010 Feb;87(2):193-202. doi: 10.1189/jlb.0508280. Epub 2009 Oct 1.

PMID:
19797297
18.

The neuropeptide calcitonin gene-related peptide (CGRP) prevents inflammatory liver injury in mice.

Kroeger I, Erhardt A, Abt D, Fischer M, Biburger M, Rau T, Neuhuber WL, Tiegs G.

J Hepatol. 2009 Aug;51(2):342-53. doi: 10.1016/j.jhep.2009.03.022. Epub 2009 May 3.

PMID:
19464067
19.

Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors.

Biburger M, Tiegs G.

J Leukoc Biol. 2008 Jul;84(1):264-79. doi: 10.1189/jlb.0607352. Epub 2008 Apr 11.

PMID:
18407967
20.

IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice.

Erhardt A, Biburger M, Papadopoulos T, Tiegs G.

Hepatology. 2007 Feb;45(2):475-85.

PMID:
17256743
21.

Kupffer cell-expressed membrane-bound TNF mediates melphalan hepatotoxicity via activation of both TNF receptors.

Kresse M, Latta M, Künstle G, Riehle HM, van Rooijen N, Hentze H, Tiegs G, Biburger M, Lucas R, Wendel A.

J Immunol. 2005 Sep 15;175(6):4076-83.

22.
23.
24.

Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors.

Wels W, Biburger M, Müller T, Dälken B, Giesübel U, Tonn T, Uherek C.

Cancer Immunol Immunother. 2004 Mar;53(3):217-26. Epub 2003 Dec 24. Review.

PMID:
14704833
25.

Neurokinin-1 receptor antagonists protect mice from CD95- and tumor necrosis factor-alpha-mediated apoptotic liver damage.

Bang R, Biburger M, Neuhuber WL, Tiegs G.

J Pharmacol Exp Ther. 2004 Mar;308(3):1174-80. Epub 2003 Nov 14.

27.

DNA structure and flexibility in the sequence-specific binding of papillomavirus E2 proteins.

Hines CS, Meghoo C, Shetty S, Biburger M, Brenowitz M, Hegde RS.

J Mol Biol. 1998 Mar 6;276(4):809-18.

PMID:
9500925
28.

Intragenic suppressors of induction-deficient TetR mutants: localization and potential mechanism of action.

Biburger M, Berens C, Lederer T, Krec T, Hillen W.

J Bacteriol. 1998 Feb;180(3):737-41.

29.

Supplemental Content

Loading ...
Support Center